November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

Stem Cell-Derived Vesicles Show Promise in Animal Study on Premature Ovarian Insufficiency

🔬 Research 2 min read 👁 4

A new preclinical study in mice suggests that extracellular vesicles derived from human stem cells may help improve ovarian function and protein expression following chemotherapy-induced damage.

🔬Research

Key points

  • Preclinical study investigates stem cell vesicles for premature ovarian insufficiency in mice
  • Vesicle treatment partially restored hormone levels and key proteins like BMP15 and GDF9
  • The research is at an early stage and requires clinical trials before human application

A recent preclinical investigation published in Nature Health Sciences explored whether extracellular vesicles extracted from human adipose-derived mesenchymal stem cells (hAD-MSC-EVs) could mitigate premature ovarian insufficiency. Conducted by researchers at the Iran University of Medical Sciences, the study examined mice in which ovarian failure was triggered using the chemotherapy drugs cyclophosphamide and busulfan. Investigators administered the vesicles via tail vein injections to evaluate their impact on hormonal levels, tissue structure, and key fertility-related proteins.

The study found that treated mice experienced partial improvements in endocrine function, marked by lowered follicle-stimulating hormone levels and higher estradiol and luteinizing hormone levels compared to untreated subjects with premature ovarian insufficiency. Histological evaluations further indicated better ovarian architecture and fewer stromal abnormalities following the treatment. Additionally, levels of crucial proteins like BMP15 and GDF9 increased in the treated animal group, reaching levels comparable to healthy controls, though corresponding messenger RNA increases remained modest.

What to know: While these findings highlight a potential pathway for future regenerative therapies, the research was performed entirely on animal models and remains at a very early stage. Readers should consult qualified medical professionals regarding personal health decisions and fertility concerns, as experimental findings do not yet translate to human clinical treatments.

Source Nature Health Sciences — nature.com/articles/s41598-026-79916-x ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.